Compare LEO & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LEO | NRC |
|---|---|---|
| Founded | 1987 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 402.8M | 278.8M |
| IPO Year | N/A | N/A |
| Metric | LEO | NRC |
|---|---|---|
| Price | $6.29 | $17.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 200.2K | 87.2K |
| Earning Date | 01-01-0001 | 01-26-2026 |
| Dividend Yield | ★ 4.01% | 3.63% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.04 | ★ 0.71 |
| Revenue | N/A | ★ $139,102,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $152.00 | ★ $24.85 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.98 | $9.76 |
| 52 Week High | $6.50 | $19.14 |
| Indicator | LEO | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 54.65 | 67.98 |
| Support Level | $6.28 | $15.37 |
| Resistance Level | $6.32 | $16.53 |
| Average True Range (ATR) | 0.05 | 0.76 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 69.44 | 84.14 |
BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products are Equity and Fixed Income Mutual Funds, Retail Money Market Funds, Government/Treasury Money Market Funds, Institutional Money Market Funds, and others. BNY Mellon and its affiliates, including BNYM Investment Adviser, INA and others involved in the management, sales, investment activities, business operations or distribution of the Fund, are engaged in businesses and have interests other than that of managing the Fund.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.